BioNexus Gene Lab Corp. Operating Lease, Liability, Current
BioNexus Gene Lab Corp. (BGLC) had Operating Lease, Liability, Current of $56.68 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Leases › Assets and Liabilities, Lessee
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Current $56.68K.
- 2026-03-31: Operating Lease, Liability, Current $58.25K.
- 2025-12-31: Operating Lease, Liability, Current $59.15K.
- 2025-09-30: Operating Lease, Liability, Current $56.80K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $56.68K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $58.25K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $59.15K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $56.80K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $55.81K 10-Q · filed 2025-08-18 |
| 2025-03-31 | $52.17K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $50.82K 10-K · filed 2026-04-14 |
| 2024-09-30 | $48.21K 10-Q · filed 2024-11-15 |
| 2024-06-30 | $53.21K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $32.51K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $34.63K 10-K · filed 2025-04-15 |
| 2023-09-30 | $33.90K 10-Q/A · filed 2024-03-26 |
| 2023-06-30 | $16.10K 10-Q · filed 2023-08-16 |
| 2023-03-31 | $16.73K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $16.57K 10-K · filed 2024-04-16 |
| 2022-09-30 | $11.78K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $14.03K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $16.41K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $18.27K 10-K · filed 2023-03-31 |
| 2021-09-30 | $18.57K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $18.47K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $16.79K 10-Q · filed 2021-05-18 |
| 2020-12-31 | $20.70K 10-K · filed 2022-04-06 |
| 2020-09-30 | $11.15K 10-Q/A · filed 2020-11-09 |
| 2020-06-30 | $11.54K 10-Q · filed 2020-08-11 |
| 2019-12-31 | $11.94K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |